Oral mucosal status and salivary IgA levels of HIV-infected children

Journal of Oral Pathology and Medicine

Volumn 42, Issue 9, 2013, Pages 705-710

  Subramaniam, Priya ^a   Kumar, Krishna ^a  

^a Oxford Dental College and Hospital   (India)

Author keywords

HIV infection; Oral mucosa; Saliva

Indexed keywords

ANTIRETROVIRUS AGENT; SALIVA PROTEIN; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; APHTHOUS ULCER; ARTICLE; CANDIDIASIS; CHEILITIS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; GINGIVA DISEASE; HAIRY LEUKOPLAKIA; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; MAJOR CLINICAL STUDY; MALE; ORAL MUCOSAL DISEASE; PIGMENTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

HIV INFECTION; ORAL MUCOSA; SALIVA;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; CANDIDIASIS, ORAL; CD4 LYMPHOCYTE COUNT; CHEILITIS; CHILD; ERYTHEMA; FEMALE; GINGIVAL DISEASES; HIV INFECTIONS; HUMANS; IMMUNOGLOBULIN A, SECRETORY; LEUKOPLAKIA, HAIRY; MALE; MOUTH DISEASES; PIGMENTATION DISORDERS; STOMATITIS, APHTHOUS;

EID: 84885922242     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12061     Document Type: Article

References (34)

1. Mittal M. AIDS in children - epidemiology, clinical course, oral manifestations and management. J Clin Pediatr Dent 2009; 34: 95-102.
2. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci 2011; 53: 203-11.
3. Centers for Disease Control Prevention. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43(RR-12): 1-10.
4. Magalhães MG, Bueno DF, Serra E, Gonçalves R. Oral manifestations of HIV positive children. J Clin Pediatr Dent 2001; 25: 103-6.
5. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002; 8(Suppl. 2): 34-9.
6. Santo AE, Tagliaferro EP, Ambrosano GM, Meneghim MC, Pereira AC. Dental status of Portuguese HIV+ patients and related variables: a multivariate analysis. Oral Dis 2010; 16: 176-84.
7. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis 2004; 10: 13-8.
8. Ramos-Gomez FJ, Flaitz C, Catapano P, Murray P, Milnes AR, Dorenbaum A. Classification, diagnostic criteria, and treatment recommendations for orofacial manifestations in HIV- infected pediatric patients. J Clin Pediatr Dent 1999; 23: 85-96.
9. Castro GF, Souza IP, Lopes S, Stashenko P, Teles RP. Salivary IgA to cariogenic bacteria in HIV-positive children and its correlation with caries prevalence and levels of cariogenic microorganisms. Oral Microbiol Immunol 2004; 19: 281-8.
10. dos Santos Pinheiro R, França TT, Ribeiro CM, Leão JC, de Souza IP, Castro GF. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era. J Oral Pathol Med 2009; 38: 613-22.
11. Pongsiriwet S, Iamaroona, Kanjanavanit S, Pattanaporn K, Krisanaprakornkit S. Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Paediatr Dent 2003; 13: 180-5.
12. Ranganathan K, Geethalakshmi E, Krishna MohanRao U, Vidya KM, Kumarasamy N, Solomon S. Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. Int J Paediatr Dent 2010; 20: 276-82.
13. Hamza OJ, Matee MI, Simon EN, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006; 18: 6-12.
14. Teanpaisan R, Nittayananta W. Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand. J Oral Pathol Med 1998; 27: 4-7.
15. Schmidt-Westhausen AM, Bendick C, Reichart PA, Samaranayake LP. Oral candidosis and associated Candida species in HIV infected Cambodians exposed to antimycotics. Mycoses 2004; 47: 435-41.
16. Sweet SP. Oral candidiasis in HIV infection. J Dent Res 1994; 73: 792-6.
17. Korting HC, Schaller M, Eder G, Hamm G, Bohmer U, Hube B. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartly proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 1999; 43: 2038-42.
18. Cerqueira DF, Portela MB, Pomarico L, Soares RM, De Souza IP, Castro GF. Examining dentinal cariouslesions as a predisposing factor for the oral prevalence of Candida spp in HIV-infected children. J Dent Child (Chic) 2007; 74: 98-103.
19. Expósito-Delgado AJ, Vallejo-Bolaños E, Martos-Cobo EG. Oral manifestations of HIV infection in infants: a review article. Med Oral Pathol Oral Cir Bucal 2004; 9: 410-20.
20. Ranganathan K, Umadevi M, Saraswathi TR, Kumarasamy N, Solomon S, Johnson N. Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singapore 2004; 33: 37-42.
21. Umadevi KMR, Ranganathan K, Pavithra S, et al. Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India. J Oral Pathol Med 2007; 36: 136-41.
22. Sapp PJ, Eversole LR, Wysocki GP. Contemporary oral and maxillofacial pathology. St. Louis, MO: Mosby Publications, 2004.
23. Valdez IH, Pizzo PA, Atkinson JC. Oral health of pediatric AIDS patients: a hospital-based study. J Dent Child 1994; 61: 114-8.
24. Ketchem L, Berkowitz RJ, McIlveen L, Forrester D, Rakusan T. Oral findings in HIV-seropositive children. Pediatr Dent 1990; 12: 143-6.
25. del Toro A, Berkowitz R, Meyerowitz C, Frenkel LM. Oral findings in asymptomatic (P-1) and symptomatic (P-2) HIV infected children. Pediatr Dent 1996; 18: 114-6.
26. Mandel ID, Barr CE, Turgeon L. Longitudinalstudy of parotid saliva in HIV-1infection. J Oral Pathol Med 1992; 21: 209-13.
27. Muller F, Holberg-Petersen M, Rollag H, Degre M, Brandtzaeg P, Froland SS. Nonspecificoral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 1992; 5: 46-51.
28. Sweet SP, Rahman D, Challacombe SJ. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva. Immunology 1995; 86: 556-9.
29. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC. Elevation of salivary antimicrobial proteins followingHIV-1 infection. J Acquir Immune Defic Syndr 1990; 3: 41-8.
30. Grimoud AM, Arnaud C, Dellamonica P, Lodter JP. Salivary defense factor concentrations in relation to oral and general parameters in HIV positive patients. Eur J Oral Sci 1998; 106: 979-85.
31. Padmanabhan V, Rai K, Hegde AM, Shetty S. Total antioxidant capacity of saliva in children with HIV. J Clin Pediatr Dent 2010; 34: 347-50.
32. Ho DD, Byington RE, Schooley RT, Flynn T, Rota TR, Hirsch MS. Infrequency of isolation of HTLV-III virus from saliva in AIDS (letter). N Engl J Med 1985; 313: 1606-7.
33. Kozlowski PA, Jackson S. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins. AIDS Res Hum Retroviruses 1992; 8: 1773-80.
34. Tabak LA. A revolution in biomedical assessment: the development of salivary diagnostics. J Dent Educ 2001; 65: 1335-9.